Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indonesia, Thailand, Vietnam Testing H1N1 Alternative Drug

This article was originally published in PharmAsia News

Executive Summary

Indonesia, Thailand and Vietnam have become central locations for testing alternative medicines for the H1N1 virus because an increasing number of patients have become resistant to existing treatments. In all three countries, clinical trials have begun on peramivir as an alternative antiviral to Roche's Tamiflu (oseltamivir), the main treatment against the virus, but reportedly facing resistant strains of the flu that are developing as a result to overuse. The seasonal flu virus also is reported becoming resistant to Tamiflu. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts